Quintrio
Home

Stock overview

NANO-X IMAGING LTD Ordinary Shares

NNOX

Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.

Last trade $0.289
Day change -$0.0313 (-9.77%)
Day range $0.266 – $0.326
Volume 1,248,048
Market cap $25M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for NNOX.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for NNOX.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures

Nanox (NASDAQ: NNOX) announced a Board-approved cost reduction plan targeting 25-30% reduction in annualized operating expenses by end of Q1 2027, including workforce reductions and operational adjustments. The company is focusing on four strategic priorities: accelerating Nanox.ARC commercialization, strengthening commercial partnerships, improving operational efficiency, and enhancing financial flexibility. However, the company continues to face substantial doubt about its ability to continue as a going concern and will require additional financing.

GlobeNewswire Inc.

Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy

Nanox AI Ltd. has entered into a distribution agreement with Technologic s.r.l., an affiliate of Tecnologie Avanzate, to commercialize its HealthOST bone solution in Italy. The collaboration leverages Tecnologie Avanzate's 50 years of experience in the Italian medical technology market to expand Nanox.AI's commercial presence and bring AI-powered bone health assessment capabilities to Italian healthcare providers.

GlobeNewswire Inc.

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Nanox Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC 3D imaging system. This marks Nanox's third Latin American market expansion this year, following Argentina and Peru. SOLME will handle marketing, distribution, installation, training, and technical support, with commercialization following a six-month regulatory POC device registration period.

GlobeNewswire Inc.

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Nanox announced a distribution agreement with Associated X-Ray Imaging Corp., a New England-based medical imaging provider, to expand deployment of the Nanox.ARC, an FDA-cleared 3D digital tomosynthesis system, across the region. The partnership leverages Associated X-Ray Imaging's established regional presence and service infrastructure to support Nanox's U.S. commercial expansion in outpatient and community-based clinical settings.

GlobeNewswire Inc.

NANO-X DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – NNOX

A securities class action lawsuit has been filed against Nano-X Imaging Ltd. (NNOX) for allegedly making false and misleading statements about operational efficiency and product demand. The lawsuit claims the company overstated efficiency gains while concealing poor alignment between production and demand, leading to increased operating expenses, cash burn, and the need for disruptive restructuring measures. Investors with losses exceeding $100,000 are encouraged to join the class action before the August 11, 2026 deadline.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.